Individualized Targeting and Neuromodulation of Late-Life Depression

Running, not enrolling · Not applicable

Conditions studied: Major Depressive Disorder

In brief

An open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.

Key facts

Study ID
NCT04543773
Run by
University of New Mexico
People needed
24
Starts
2024-10-01
Expected to finish
2026-09-01
Last updated by the study team
2026-08-04

Who can join

Age: 60 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.